These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

313 related items for PubMed ID: 6725520

  • 1. Dose-dependent suppression of norepinephrine appearance rate in plasma by clonidine in man.
    Veith RC, Best JD, Halter JB.
    J Clin Endocrinol Metab; 1984 Jul; 59(1):151-5. PubMed ID: 6725520
    [Abstract] [Full Text] [Related]

  • 2. Age differences in the plasma clearance mechanisms for epinephrine and norepinephrine in humans.
    Morrow LA, Linares OA, Hill TJ, Sanfield JA, Supiano MA, Rosen SG, Halter JB.
    J Clin Endocrinol Metab; 1987 Sep; 65(3):508-11. PubMed ID: 3624412
    [Abstract] [Full Text] [Related]

  • 3. Age and alpha-2 adrenergic regulation of plasma norepinephrine kinetics in humans.
    Featherstone JA, Veith RC, Flatness D, Murburg MM, Villacres EC, Halter JB.
    J Gerontol; 1987 May; 42(3):271-6. PubMed ID: 3033053
    [Abstract] [Full Text] [Related]

  • 4. Cardiovascular and catecholamine response to clonidine in obese subjects.
    Del Rio G, Zizzo G, Bonati ME, Macdonald IA, Velardo A.
    Int J Obes Relat Metab Disord; 1995 Jul; 19(7):475-9. PubMed ID: 8520637
    [Abstract] [Full Text] [Related]

  • 5. Effect of pentobarbital anesthesia on plasma norepinephrine kinetics in dogs.
    Best JD, Taborsky GJ, Flatness DE, Halter JB.
    Endocrinology; 1984 Sep; 115(3):853-7. PubMed ID: 6378605
    [Abstract] [Full Text] [Related]

  • 6. Epinephrine plasma metabolic clearance rates and physiologic thresholds for metabolic and hemodynamic actions in man.
    Clutter WE, Bier DM, Shah SD, Cryer PE.
    J Clin Invest; 1980 Jul; 66(1):94-101. PubMed ID: 6995479
    [Abstract] [Full Text] [Related]

  • 7. Effect of clonidine on sympathoadrenal response during sodium nitroprusside hypotension.
    Bloor BC, Finander LS, Flacke WE, Van Etten A.
    Anesth Analg; 1986 May; 65(5):469-74. PubMed ID: 3963432
    [Abstract] [Full Text] [Related]

  • 8. Increased plasma norepinephrine and sympathetic nervous activity in essential hypertensive and uremic humans: effects of clonidine.
    Izzo JL, Santarosa RP, Larrabee PS, Smith RJ, Kallay MC.
    J Cardiovasc Pharmacol; 1987 May; 10 Suppl 12():S225-9. PubMed ID: 2455184
    [Abstract] [Full Text] [Related]

  • 9. Effects of yohimbine on human sympathetic nervous system function.
    Murburg MM, Villacres EC, Ko GN, Veith RC.
    J Clin Endocrinol Metab; 1991 Oct; 73(4):861-5. PubMed ID: 1890156
    [Abstract] [Full Text] [Related]

  • 10. Effect of the centrally acting agent clonidine on circulating catecholamines at rest and during exercise. Comparison with the effects of beta-blocking agents.
    Mäurer W, Hausen M, Krämer B, Kübler W.
    Chest; 1983 Feb; 83(2 Suppl):366-9. PubMed ID: 6129951
    [Abstract] [Full Text] [Related]

  • 11. Effect of clonidine on the thermic effect of feeding in humans.
    Schwartz RS, Jaeger LF, Veith RC.
    Am J Physiol; 1988 Jan; 254(1 Pt 2):R90-4. PubMed ID: 3337274
    [Abstract] [Full Text] [Related]

  • 12. Fentanyl, esmolol, and clonidine blunt the transient cardiovascular stimulation induced by desflurane in humans.
    Weiskopf RB, Eger EI, Noorani M, Daniel M.
    Anesthesiology; 1994 Dec; 81(6):1350-5. PubMed ID: 7992902
    [Abstract] [Full Text] [Related]

  • 13. Role of sympathetic nerve inhibition and body sodium-volume state in the antihypertensive action of clonidine in essential hypertension.
    Campese VM, Romoff M, Telfer N, Weidmann P, Massry SG.
    Kidney Int; 1980 Sep; 18(3):351-7. PubMed ID: 7007709
    [Abstract] [Full Text] [Related]

  • 14. Age differences in plasma norepinephrine kinetics in humans.
    Veith RC, Featherstone JA, Linares OA, Halter JB.
    J Gerontol; 1986 May; 41(3):319-24. PubMed ID: 3700981
    [Abstract] [Full Text] [Related]

  • 15. Increased plasma and cerebrospinal fluid norepinephrine in older men: differential suppression by clonidine.
    Raskind MA, Peskind ER, Veith RC, Beard JC, Gumbrecht G, Halter JB.
    J Clin Endocrinol Metab; 1988 Feb; 66(2):438-43. PubMed ID: 3339115
    [Abstract] [Full Text] [Related]

  • 16. Effects of sympathetic inhibition on blood pressure and renal responses to central hypervolaemia in normal humans.
    Kreutz R, Kruse HJ, Overlack A, Stumpe KO, Kolloch RE.
    Acta Physiol Scand; 1996 Jan; 156(1):1-7. PubMed ID: 8866880
    [Abstract] [Full Text] [Related]

  • 17. Suppression of norepinephrine appearance rate in plasma by diazepam in humans.
    Roy-Byrne PP, Lewis N, Villacres E, Greenblatt DJ, Shader RI, Veith RC.
    Life Sci; 1988 Jan; 43(20):1615-23. PubMed ID: 3193849
    [Abstract] [Full Text] [Related]

  • 18. Abnormal norepinephrine release in uremia.
    Izzo JL, Sterns RH.
    Kidney Int Suppl; 1983 Dec; 16():S221-3. PubMed ID: 6588253
    [Abstract] [Full Text] [Related]

  • 19. Norepinephrine kinetics during orthostatic stress in congestive heart failure.
    Davis D, Sinoway LI, Robison J, Minotti JR, Day FP, Baily R, Zelis R.
    Circ Res; 1987 Oct; 61(4 Pt 2):I87-90. PubMed ID: 3652408
    [Abstract] [Full Text] [Related]

  • 20. Release and clearance rates of epinephrine in man: importance of arterial measurements.
    Best JD, Halter JB.
    J Clin Endocrinol Metab; 1982 Aug; 55(2):263-8. PubMed ID: 7085853
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.